PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,436,245 | -35.2% | 138,500 | -10.5% | 0.00% | – |
| Q2 2023 | $2,214,846 | +537.2% | 154,668 | +217.7% | 0.00% | – |
| Q1 2023 | $347,583 | -58.1% | 48,681 | -34.2% | 0.00% | – |
| Q4 2022 | $830,414 | +30.8% | 74,012 | +29.1% | 0.00% | – |
| Q3 2022 | $635,000 | +43.7% | 57,342 | +9.5% | 0.00% | – |
| Q2 2022 | $442,000 | +14.5% | 52,372 | +84.8% | 0.00% | – |
| Q1 2022 | $386,000 | -42.5% | 28,337 | -16.9% | 0.00% | – |
| Q4 2021 | $671,000 | +191.7% | 34,117 | +376.3% | 0.00% | – |
| Q3 2021 | $230,000 | -84.3% | 7,163 | -83.7% | 0.00% | – |
| Q4 2020 | $1,464,000 | +624.8% | 44,078 | +579.0% | 0.00% | – |
| Q4 2019 | $202,000 | – | 6,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,760,869 | $39,000,212 | 12.45% |
| Frazier Life Sciences Management, L.P. | 10,109,279 | $104,833,223 | 6.96% |
| Decheng Capital Management III (Cayman), LLC | 850,000 | $8,814,500 | 2.94% |
| Carlyle Group Inc. | 3,496,808 | $36,191,963 | 1.57% |
| Ghost Tree Capital, LLC | 395,000 | $4,096,150 | 1.35% |
| Newtyn Management, LLC | 500,000 | $5,185,000 | 1.28% |
| Altium Capital Management LP | 220,000 | $2,281,400 | 1.19% |
| StepStone Group LP | 422,085 | $4,377,021 | 0.98% |
| MPM BioImpact LLC | 347,332 | $3,601,833 | 0.96% |
| NEA Management Company, LLC | 1,276,595 | $12,238,290 | 0.94% |